| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $231K | -10.2% |
| Cost of Revenue | $11K | -87.9% |
| Gross Profit | $220K | +34.9% |
| R&D Expense | $335K | +36.8% |
| SG&A Expense | $1.2M | +10.6% |
| Operating Income | -$7.3M | +15.7% |
| Pre-tax Income | -$14.2M | -15.5% |
| Net Income | -$14.0M | -13.9% |
| EPS (Basic) | -$0.02 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $38K | -46.8% |
| Current Assets | $3.4M | +300.9% |
| Total Assets | $13.1M | +23.4% |
| Current Liabilities | $18.4M | +70.7% |
| Long-term Debt | $1.8M | +0.0% |
| Total Liabilities | $25.0M | +98.8% |
| Stockholders' Equity | -$11.9M | -180.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.9M | -3.6% |
| Investing Cash Flow | -$133K | +93.6% |
| Financing Cash Flow | $5.9M | -16.3% |
| +33.3% |
| EPS (Diluted) | -$0.02 | +33.3% |